GGrantIndex
← Leaderboards

Allison M Bradbury

Research Inst Nationwide Children'S Hosp

$1,820,728
Attributed
$2,626,373
Total exposure
5
Grants
4
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $993.5K · FY201625
$1M$750K$500K$250K$0
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$2,626,373 · 5

By mechanism

R01$1,186,635 · 1
R00$686,113 · 1
R21$424,655 · 1
K99$178,352 · 1
F32$150,618 · 1

Top collaborators

Most similar at Research Inst Nationwide Children'S Hosp

Same institution · by research overlap

Others in their field

Top investigators on “Biochemical

Research focus

BiochemicalGene TherapyCellsAffectCessation Of LifeDisease ProgressionBrainTreatment EfficacyOligodendrogliaGenesSpinal CordTissuesDependovirusMyelinMediatingGloboid Cell LeukodystrophyLeukodystrophyMutationAnimal ModelGalactosylceramidesBiodistributionCell TypeCanis FamiliarisBreeding

Grant awards (11)

Uncovering mechanisms and developing novel therapeutic strategies for TBCD-related developmental and epileptic encephalopathy$568,866
R01 · FY2025 · NS · contact PI
Role of Microglia in Vanishing White Matter Disease Leukodystrophy$424,655
R21 · FY2025 · HD
Uncovering mechanisms and developing novel therapeutic strategies for TBCD-related developmental and epileptic encephalopathy$617,769
R01 · FY2024 · NS · contact PI
Temporospatial psychosine accumulation and targeted adeno-associated virus (AAV) gene therapy in canine Krabbe disease$244,020
R00 · FY2022 · HD · contact PI
Temporospatial psychosine accumulation and targeted adeno-associated virus (AAV) gene therapy in canine Krabbe disease$193,093
R00 · FY2021 · HD · contact PI
Temporospatial psychosine accumulation and targeted adeno-associated virus (AAV) gene therapy in canine Krabbe disease$249,000
R00 · FY2020 · HD · contact PI
Temporospatial psychosine accumulation and targeted adeno-associated virus (AAV) gene therapy in canine Krabbe disease$89,176
K99 · FY2019 · HD · contact PI
Temporospatial psychosine accumulation and targeted adeno-associated virus (AAV) gene therapy in canine Krabbe disease$89,176
K99 · FY2018 · HD · contact PI
Lentiviral-mediated Hematopoietic Stem Cell Gene Therapy for Canine Globoid Cell Leukodystrophy$35,334
F32 · FY2018 · NS · contact PI
Lentiviral-mediated Hematopoietic Stem Cell Gene Therapy for Canine Globoid Cell Leukodystrophy$59,166
F32 · FY2017 · NS · contact PI
Lentiviral-mediated Hematopoietic Stem Cell Gene Therapy for Canine Globoid Cell Leukodystrophy$56,118
F32 · FY2016 · NS · contact PI